BioStem Technologies Chief Commercial Officer Hassett Barry exercised Options for 500 shares at $0 per share, leaving him with 5,003 shares and 4,497 derivative securities. The transaction represented about 10.0% of the resulting share holding and about 10.0% of the prior derivative-securities holding, giving investors the disclosed ownership context.

Key Highlights

  • Hassett Barry’s exercise represented about 10.0% of his resulting share holding.
  • The transaction used code M, the classification for an option exercise.
  • Barry’s prior derivative-securities holding was represented by a transaction equal to about 10.0%.

BioStem Technologies, Inc. (NASDAQ: BSEM) Chief Commercial Officer Hassett Barry exercised options for 500 shares at $0 per share on Sep 9, 2026. The same transaction covered 500 derivative securities.

Option Exercise Leaves Separate Holdings Barry held 5,003 shares after the transaction.

He also owned 4,497 derivative securities following the exercise. The share and derivative-security figures are reported separately. The exercise price for the shares was $0 per share.

transaction represented about 10.0% of Barry’s resulting share holding. Separately, it represented about 10.0% of his prior derivative-securities holding. Those percentages apply to different categories, with the first tied to shares held after the transaction and the second tied to derivative securities held before it.